EZH2 and head and neck cancer: However, Nienstedt's study found a relatively low percentage of EZH2 expression in tongue cancer (6%) compared to other cohorts (39–100%), indicating potential differences in the molecular environment among different mucosal regions of head and neck cancer that could influence EZH2 [62, 63].